0.41 USD
↘ 0.01 (2.45%)LIVE (AS OF 12:48 PM EST)
Aprea Therapeutics, Inc. Common stock (APRE) trades at $0.41 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, APRE trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Nov 13, 2026.